Patents by Inventor Ludwig Neyses

Ludwig Neyses has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PLASMA MEMBRANE CALCIUM ATPASE (PMCA) INHIBITORS TO INHIBIT SPERM MOBILITY
    Publication number: 20120027815
    Abstract: The invention relates to the use of plasma membrane calcium ATPase (PMCA) inhibitors for inhibiting sperm mobility to achieve a contraceptive effect. The invention further relates to contraceptive agents comprising one or more PMCA inhibitors.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 2, 2012
    Inventor: Ludwig Neyses
  • Methods of diagnosing infertility by detecting PMCA4 mutations
    Patent number: 8013009
    Abstract: The invention relates to the use of plasma membrane calcium ATPase (PMCA) inhibitors for inhibiting sperm mobility to achieve a contraceptive effect. The invention further relates to contraceptive agents comprising one or more PMCA inhibitors.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: September 6, 2011
    Inventor: Ludwig Neyses
  • Use of plasma membrane calcium atpase (pmca) inhibitors for inhibiting sperm mobility
    Publication number: 20060276529
    Abstract: The invention relates to the use of plasma membrane calcium ATPase (PMCA) inhibitors for inhibiting sperm mobility to achieve a contraceptive effect. The invention further relates to contraceptive agents comprising one or more PMCA inhibitors.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 7, 2006
    Inventor: Ludwig Neyses
  • Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
    Publication number: 20050148560
    Abstract: The present invention relates to the use of the ER? agonists 8?-Vinyl-estra-1,3,5(10)-trien-3,17?-diol and 17?-Fluor-9?-vinyl-estra-1,3,5(10)-trien-3,16?-diol for production of medicaments for the prevention and/or treatment of hypertensive heart disease, especially for the prevention and/or treatment of one or more of the conditions selected from the group of (1) hypertension, (2) cardiac hypertrophy and (3) heart failure.
    Type: Application
    Filed: November 24, 2004
    Publication date: July 7, 2005
    Inventors: Karl-Heinrich Fritzemeier, Christa Hegele-Hartung, Ludwig Neyses, Theo Pelzer, Olaf Peters